Monomil Xl (Isosorbide 5 Mononitrate)

Isosorbide 5 Mononitrate is used in the management of coronary artery disease and related angina syndromes.

• Chronic stable angina pectoris: reduces the frequency and severity of angina episodes.
• Prevention of angina attacks: provides prophylactic relief during physical exertion or stress.
• Exercise‑induced angina: improves exercise tolerance by enhancing myocardial oxygen supply.

• Isosorbide 5 Mononitrate is metabolized to release nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting increase in cyclic GMP causes relaxation of both venous and arterial vessels, lowering preload and afterload, and thereby improving myocardial oxygen delivery while reducing cardiac workload.

Isosorbide 5 Mononitrate may cause a range of adverse reactions, most of which are dose‑related and transient.

Common Side Effects

• Headache: throbbing or pressure‑type pain, often occurring shortly after dosing.
• Dizziness or light‑headedness: related to vasodilation and blood pressure fall.
• Flushing: warmth and redness of the skin, especially on the face and neck.
• Nausea: mild gastrointestinal upset.
• Palpitations: awareness of heartbeats, usually benign.
• Hypotension: mild drop in blood pressure, may cause faintness.

Serious or Rare Side Effects

• Severe hypotension: marked blood pressure reduction requiring medical attention.
• Syncope: sudden loss of consciousness due to inadequate cerebral perfusion.
• Allergic reactions: rash, itching, or swelling that may progress to anaphylaxis.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions.
• Myocardial infarction: extremely rare but reported in susceptible individuals.
• Methemoglobinemia: abnormal hemoglobin that impairs oxygen transport.

Before initiating therapy with Isosorbide 5 Mononitrate, consider the following safety measures.

• Dose titration: start with the lowest effective dose and increase gradually as tolerated.
• Concomitant nitrates: avoid using other nitrate preparations to prevent additive hypotension.
• Blood pressure monitoring: check regularly, especially after dose changes.
• Severe anemia: use with caution, as reduced oxygen‑carrying capacity may exacerbate symptoms.
• Hypersensitivity: discontinue if any allergic reaction occurs.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Isosorbide 5 Mononitrate can interact with several drug classes; awareness of major and moderate interactions helps mitigate risk.

Major Interactions (Avoid)

• Other organic nitrates: additive vasodilatory effect may cause profound hypotension.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of severe blood pressure drop.
• Sodium nitrite or nitroglycerin: excessive nitrate load leading to toxicity.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents (beta‑blockers, ACE inhibitors, calcium channel blockers): may enhance blood pressure‑lowering effect.
• Diuretics: can potentiate orthostatic hypotension.
• Alcohol: may increase dizziness and vasodilatory response.
• Antiplatelet or anticoagulant drugs: monitor for bleeding tendency.
• Certain antibiotics (e.g., macrolides): may affect nitrate metabolism.